Are We Ready For Disease-Modifying Therapies In Alzheimer’s Disease? The Role Of MRI Biomarkers

Dirk Smeets

$1.99

Summary
Transcript
Heather Sandison, N.D. 

Welcome back to the Reverse Alzheimer’s Summit. I’m your host, Dr. Heather Sandison and I’m so pleased to have Dirk Smeets here today of icometrix. Dirk Smeets is the current Chief Technology Officer at icometrix. Trained as a biomedical engineer, he obtained his PhD in medical image analysis in 2012, after joining icometrix, he took different roles covering responsibilities in research and development, quality management, information security management, marketing, sales management, and strategic partnerships. Today, he is responsible for bringing new products to the market, demonstrating their clinical value and implementing them to be of value for the icometrix customers. Dirk, thanks so much for joining us today.

Related Videos

The Science Of Slumber: How Low Oxygen Levels At Night Can Lead To Memory Loss And Dementia OR Elixer Of Life: Oxygen Therapy For Brain Function And Detox​

Mark Squibb

Mold & Detox

Margaret Christensen, MD

Purchase Now

CARD DETAILS

TOTAL: $

Sign-in

Login to get access to DrSummits wide selection of expert videos, your summit or video purchases.

Cart

Your cart is currently empty.

Return to shop

Sign up

Name*
Password*
Consent*

Already have an account? Log In